Results 6,341-6,360 of 9,393 for speaker:Alex White

Written Answers — Department of Health: Medicinal Products (5 Feb 2013)

Alex White: The prices of drugs vary between countries for a number of reasons, including different prices set by manufacturers, different wholesale and pharmacy mark-ups, different dispensing fees and different rates of VAT. In recent years, a number of changes to the pricing and reimbursement system have been successfully introduced in Ireland. These have resulted in reductions in the prices of...

Written Answers — Department of Health: Long-Term Illness Scheme Entitlements (31 Jan 2013)

Alex White: The Programme for Government commits to reforming the current public health system by introducing Universal Health Insurance with equal access to care for all. As part of this, the Government is committed to introducing, on a phased basis, GP care without fees within its first term of office. Primary legislation is required to give effect to Government commitment to introduce a universal GP...

Written Answers — Department of Health: Medical Card Applications (31 Jan 2013)

Alex White: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible.

Written Answers — Department of Health: Health Service Executive Staff (31 Jan 2013)

Alex White: I propose to take Questions Nos. 202 and 203 together. The HSE National Audiology Review Group Report, published in April 2011, made recommendations to address inconsistencies and shortcomings in audiology services including recommendations on governance and staffing matters. The HSE audiology service currently employs 72.37 Whole Time Equivalents (WTEs). A new post of National Clinical...

Written Answers — Department of Health: Medicinal Products (31 Jan 2013)

Alex White: I propose to take Questions Nos. 206 and 209 together. The HSE has received an application for the inclusion of Kalydeco (generic name: Ivacaftor) in the GMS and community drugs schemes which is being considered in line with the procedures agreed with the Irish Pharmaceutical Healthcare Association (IPHA). These include clearly documented processes and timelines for the assessment of new...

Written Answers — Department of Health: Medical Products (31 Jan 2013)

Alex White: The Health Service Executive is responsible for granting GMS codes. The HSE has therefore been asked to examine this matter and to reply to the Deputy as soon as possible.

Written Answers — Department of Health: Health Services (31 Jan 2013)

Alex White: Surplus unused products (collected by HSE clients from HSE Health Centres) which are still in the original packaging can be returned by clients to the relevant health centre for re-distribution.

Written Answers — Department of Health: Medical Card Applications (31 Jan 2013)

Alex White: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible.

Written Answers — Department of Health: Dispensing Fees (31 Jan 2013)

Alex White: Medical card holders are required to pay a €1.50 charge (per item) for medicines and other prescription items supplied to them by community pharmacists, subject to a cap of €19.50 per month for each person or family. Prior to 1 January 2013, the prescription charge was €0.50 per item. Charges are not payable in respect of items supplied under the Long Term Illness...

Written Answers — Department of Health: Medicinal Products (31 Jan 2013)

Alex White: The following products are on the HSE's Primary Care Reimbursement Service list of reimbursable items: Pradaxa Caps. 110 mg. 10 (5 Day Dose); Pradaxa Caps. 110 mg. 60 (30 Day Dose); Pradaxa Caps. 75 mg. 10 (5 Day Dose); Pradaxa Caps. 75 mg. 60 (30 Day Dose); Pradaxa Hard Caps. 150 mg. 60 (30 Day Dose).

Written Answers — Department of Health: Medical Card Applications (31 Jan 2013)

Alex White: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible.

Written Answers — Department of Health: Health Services (31 Jan 2013)

Alex White: The HSE provides orthodontic treatment to patients based on their level of clinical need. An individual's access to orthodontic treatment is determined against a set of clinical guidelines and priority is given to patients with greatest needs. The HSE has been asked to examine the specific query raised by the Deputy and to reply to him as soon as possible.

Seanad: Water Fluoridation: Motion (30 Jan 2013)

Alex White: A simple bald call for a review in the manner in which the motion is drawn gives rise to the suggestion, if not the conclusion, that there is a problem with the policy. I do not accept we should form the view that the policy should be set aside. The policy is backed up by the strongest scientific evidence. That is not to say that other voices cannot be heard. They can be heard and they...

Seanad: Water Fluoridation: Motion (30 Jan 2013)

Alex White: I acknowledge and thank the Senators for holding this debate. I commend everyone who contributed, including Senators Norris and Quinn, who tabled this motion. The Government will not support it in its current form, but the Government has proposed an amendment that provides for the continuing review of this important issue of public interest and concern. As such, the amendment seems to...

Seanad: Water Fluoridation: Motion (30 Jan 2013)

Alex White: They have whiter hair or greyer hair anyway.

Seanad: Water Fluoridation: Motion (30 Jan 2013)

Alex White: One could not have that.

Seanad: Water Fluoridation: Motion (30 Jan 2013)

Alex White: Careful now.

Written Answers — Department of Health: Dental Services (30 Jan 2013)

Alex White: Dental services to children up to 16 years are provided by the Public Dental Service of the HSE. The service is targeted at children at key stages in their development. Children are given dental examinations and any follow-up treatment required at these stages. When required, emergency dental treatment is available to all children up to 16 years. The HSE has been asked to examine the specific...

Written Answers — Department of Health: EU Presidency Priorities (29 Jan 2013)

Alex White: I propose to take Questions Nos. 644 and 645 together. The Clinical Trials Proposal and the two Medical Devices Proposals (one on medical devices and one on in vitro diagnostic medical devices), are high priority proposals for the Irish Presidency and have been identified as two of the four priority areas for the Health Presidency programme. The objective of the Clinical Trials proposal is...

Written Answers — Department of Health: Medical Card Applications (29 Jan 2013)

Alex White: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible.